TrialEuropean heart journal2014

A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.

Piotr Ponikowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.